Angion Biomedica Current Cash

Angion Biomedica (ANGN) currently reports a current cash of $15M as of March 2026. That compares with $18M in the prior-year period — down 18.5% year over year. Use the charts on this page to explore Angion Biomedica's current cash history and peer comparisons.

Angion Biomedica's current cash decreased from $18M to $15M — a 18.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Angion Biomedica reported $15M in current cash as of March 2026. That compares with $18M in the prior-year period — down 18.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Angion Biomedica, and consider following ANGN for alerts when major investors trade the stock.

Angion Biomedica is classified in the Healthcare sector. On current cash, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANGN with unrelated industries.